Stock DNA
Pharmaceuticals & Biotechnology
GBP 28 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.62
-999,999.00%
9.78
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2014)
Net Profit:
-22 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.45%
0%
10.45%
6 Months
70.11%
0%
70.11%
1 Year
-3.27%
0%
-3.27%
2 Years
-61.05%
0%
-61.05%
3 Years
-70.4%
0%
-70.4%
4 Years
-81.95%
0%
-81.95%
5 Years
0%
0%
0.0%
Arecor Therapeutics Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.40%
EBIT Growth (5y)
1.37%
EBIT to Interest (avg)
-4.37
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.44
EV to EBIT
-10.18
EV to EBITDA
-10.75
EV to Capital Employed
28.49
EV to Sales
30.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-279.78%
ROE (Latest)
-835.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Bearish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'14 - YoY
Mar'14
Mar'13
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.00
-0.60
-66.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-21.70
-0.60
-3,516.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2014 is 0.00% vs 0.00% in Mar 2013
Consolidated Net Profit
YoY Growth in quarter ended Mar 2014 is -3,516.67% vs 0.00% in Mar 2013
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
2.40
1.20
100.00%
Operating Profit (PBDIT) excl Other Income
-11.30
-6.50
-73.85%
Interest
0.00
0.50
-100.00%
Exceptional Items
-0.20
-0.50
60.00%
Consolidate Net Profit
-9.30
-6.20
-50.00%
Operating Profit Margin (Excl OI)
-4,852.30%
-5,718.50%
86.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 100.00% vs -29.41% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is -50.00% vs -121.43% in Dec 2021
About Arecor Therapeutics Plc 
Arecor Therapeutics Plc
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






